The Workbench · Craft
An MDEL licenses the company; an MDL licenses the device
This blog has already covered how the Medical Device Single Audit Program lets one audit satisfy five regulators at once, Health Canada among them, because Health Canada made MDSAP certification mandatory for Class II, III, and IV devices in 2019. That post treated Health Canada as one line in a five-country list. Underneath that requirement sits a licensing structure most manufacturers used to a single-instrument market never have to draw at home: the authorization to handle devices at all, and a specific device's own authorization to be sold, are two different instruments under the Medical Devices Regulations (SOR/98-282), issued to different holders, and only one of them exists for a Class I device.
Two questions, two instruments
Part 1 of SOR/98-282 governs the Medical Device Establishment Licence, or MDEL — an authorization tied to an activity a company performs, such as manufacturing, importing, or distributing devices, not to any specific device the company happens to sell. Part 3 governs the Medical Device Licence, or MDL, which authorizes a specific device or device family for the Canadian market on the strength of evidence about that device's own safety, effectiveness, and quality. A company can hold an MDEL without a single device it distributes carrying its own MDL, and a device's MDL says nothing on its own about which companies in that device's supply chain are authorized to move it.
Class I never reaches the device instrument at all
Health Canada's four-class risk scheme runs Class I through IV, and only Class II, III, and IV devices go through the MDL review Part 3 sets out — a review whose rigor scales with class, from a shorter attestation-based path at Class II to a full evidentiary submission, often built on an ISO 13485 or MDSAP quality-system certificate, at Class III and IV. Class I has no device-licence step at all; the Regulations simply don't route a Class I device through Part 3. A manufacturer moving a device from a market where every class carries some form of individual device authorization can easily assume Canada works the same way at its lowest risk tier. It doesn't — the device itself is never licensed, only the company handling it is.
The company-side instrument reaches further than manufacturers
The MDEL isn't limited to manufacturers, and it isn't limited to higher-risk devices either. Importers and distributors of a device of any class need their own MDEL, independent of whether the device they're moving already carries an MDL — meaning a single Class III device can have one MDL on file for the device itself and several separate MDELs on file for the manufacturer, the importer, and the distributor each handling it. Class I manufacturers need an MDEL too, with one narrow carve-out: a manufacturer selling a Class I device directly to the end consumer, rather than through an intermediate distribution channel, falls outside the MDEL requirement for that activity. A market-access file that tracks “Canada: cleared” as one line has usually collapsed several distinct licence holders, each with its own renewal cycle, into a single status that doesn't belong to any one of them.
An MDEL still commits a company to real procedures
Holding an MDEL isn't a formality that ends at the application. An establishment licence holder has to maintain documented procedures meeting the Regulations' own requirements for distribution records, complaint handling, recalls, and mandatory incident reporting, plus installation, servicing, and corrective-action procedures where those activities apply to what the company actually does — and Health Canada inspects MDEL holders periodically against those same procedures and records. A company that treats the MDEL as paperwork separate from its quality system is missing that the licence and the quality system are, in Health Canada's own inspection practice, the same file.
Where this meets the file
A Canada market-access record needs the MDEL and the MDL tracked as two separate fields, each against its own holder, its own class-based trigger, and its own renewal date — not folded into a single country-level status line the way a market with one combined instrument might get away with. A licensing worksheet built around that split, alongside the MDSAP certificate Class II through IV manufacturers increasingly rely on to support their own MDL submission, is previewed in the launch catalog. If your program tracks Canada's two instruments differently, the shelf takes that correction directly.
The Regulatory Toolkit launches soon — a free shelf of source-mapped templates, checklists and browser-only tools for regulatory teams. Get one email when it opens, or contribute a template.